Eco R1 Capital, LLC Uni Qure N.V. Call Options Transaction History
Eco R1 Capital, LLC
- $2.14 Billion
- Q4 2024
Call Options
1 transactions
Others Institutions Holding QURE
# of Institutions
169Shares Held
46.5MCall Options Held
1.97MPut Options Held
382K-
Vestal Point Capital, LP New York, NY3.03MShares$42.9 Million3.17% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.45MShares$34.8 Million2.18% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.18MShares$30.8 Million0.56% of portfolio
-
Franklin Resources Inc San Mateo, CA1.99MShares$28.2 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.93MShares$27.3 Million0.0% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $663M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...